Ignite Creation Date:
2024-05-06 @ 6:00 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05500807
Status:
RECRUITING
Last Update Posted:
2023-03-01
First Post:
2022-08-12
Brief Title:
Emicizumab for Severe Von Willebrand Disease VWD and VWDHemophilia A
Sponsor:
Organization:
Bleeding and Clotting Disorders Institute Peoria Illinois